H6PD
GDH/6PGL endoplasmic bifunctional protein
Also known as: G6PE_HUMAN, GDH, H6PDH
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- O95479
- Gene
- H6PD
- Ensembl
- ENSG00000049239
- Chromosome
- 1
- Canonical length
- 791 aa
- Protein class
- Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins
- Subcellular location
- Cytosol
- Secretome location
- Intracellular and membrane
- Quaternary structure
- Homodimer
OverviewNCBI Gene
There are 2 forms of glucose-6-phosphate dehydrogenase. G form is X-linked and H form, encoded by this gene, is autosomally linked. This H form shows activity with other hexose-6-phosphates, especially galactose-6-phosphate, whereas the G form is specific for glucose-6-phosphate. Both forms are present in most tissues, but H form is not found in red cells. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
791 residues, UniProt reviewed canonical sequence.
>O95479|H6PD
1 MWNMLIVAMC LALLGCLQAQ ELQGHVSIIL LGATGDLAKK YLWQGLFQLY LDEAGRGHSF
61 SFHGAALTAP KQGQELMAKA LESLSCPKDM APSHCAEHKD QFLQLSQYRQ LKTAEDYQAL
121 NKDIEAQLQH AGLREAGRIF YFSVPPFAYE DIARNINSSC RPGPGAWLRV VLEKPFGHDH
181 FSAQQLATEL GTFFQEEEMY RVDHYLGKQA VAQILPFRDQ NRKALDGLWN RHHVERVEII
241 MKETVDAEGR TSFYEEYGVI RDVLQNHLTE VLTLVAMELP HNVSSAEAVL RHKLQVFQAL
301 RGLQRGSAVV GQYQSYSEQV RRELQKPDSF HSLTPTFAAV LVHIDNLRWE GVPFILMSGK
361 ALDERVGYAR ILFKNQACCV QSEKHWAAAQ SQCLPRQLVF HIGHGDLGSP AVLVSRNLFR
421 PSLPSSWKEM EGPPGLRLFG SPLSDYYAYS PVRERDAHSV LLSHIFHGRK NFFITTENLL
481 ASWNFWTPLL ESLAHKAPRL YPGGAENGRL LDFEFSSGRL FFSQQQPEQL VPGPGPAPMP
541 SDFQVLRAKY RESPLVSAWS EELISKLAND IEATAVRAVR RFGQFHLALS GGSSPVALFQ
601 QLATAHYGFP WAHTHLWLVD ERCVPLSDPE SNFQGLQAHL LQHVRIPYYN IHPMPVHLQQ
661 RLCAEEDQGA QIYAREISAL VANSSFDLVL LGMGADGHTA SLFPQSPTGL DGEQLVVLTT
721 SPSQPHRRMS LSLPLINRAK KVAVLVMGRM KREITTLVSR VGHEPKKWPI SGVLPHSGQL
781 VWYMDYDAFL GLocalizationUniProt · AlphaFold · HPA
Whether an antibody against H6PD can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.24
- Highest tissue expression
- 89 nTPM
Expression across tissuesHPA
Tissue
- liver: 89 nTPM
- salivary gland: 53 nTPM
- skeletal muscle: 45 nTPM
- ovary: 42 nTPM
- skin: 34 nTPM
- adrenal gland: 30 nTPM
Single-cell type
- hepatocytes: 195 nCPM
- myonuclei: 140 nCPM
- salivary acinar cells: 132 nCPM
- mesothelial cells: 115 nCPM
- neutrophil progenitors: 105 nCPM
- thymic myoid cells: 105 nCPM
Immune cell
- intermediate monocyte: 2.4 nTPM
- classical monocyte: 2.3 nTPM
- non-classical monocyte: 2.3 nTPM
- gdT-cell: 1.6 nTPM
- naive B-cell: 1.6 nTPM
- basophil: 1.5 nTPM
Brain region
- choroid plexus: 45 nTPM
- medulla oblongata: 37 nTPM
- basal ganglia: 30 nTPM
- thalamus: 29 nTPM
- midbrain: 28 nTPM
- white matter: 28 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about H6PD.
Disease | AllUniProt
Conditions H6PD is implicated in, by any mechanism.
- Cortisone reductase deficiency 1 (CORTRD1) MIM:604931
Disease | GeneticClinVar
8 pathogenic / likely-pathogenic of 325 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Cortisone reductase deficiency 1
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.94
- gnomAD pLI
- 0
- gnomAD missense Z
- -1.13
- DepMap mean gene effect
- 0.07
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- glucose metabolic process
- pentose-phosphate shunt, oxidative branch
- regulation of cortisol biosynthetic process
- response to alcohol
- response to nutrient levels
Molecular functions
- 6-phosphogluconolactonase activity
- carbohydrate binding
- glucose-6-phosphate dehydrogenase activity
- NADP binding
- glucose 1-dehydrogenase (NAD+) activity
- glucose 1-dehydrogenase (NADP+) activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Glucose-6-phosphate dehydrogenase
- 6-phosphogluconolactonase, DevB-type
- Glucosamine/galactosamine-6-phosphate isomerase
- Glucose-6-phosphate dehydrogenase, active site
- Glucose-6-phosphate dehydrogenase, NAD-binding
- Glucose-6-phosphate dehydrogenase, C-terminal
- NAD(P)-binding domain superfamily
- NagB/RpiA transferase-like
- Glucose-6-phosphate dehydrogenase, NAD binding domain
- Glucosamine-6-phosphate isomerases/6-phosphogluconolactonase
- Glucose-6-phosphate dehydrogenase, C-terminal domain
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of H6PD in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads H6PD as an antibody target. Whether an autoantibody or antibody against H6PD could matter depends on whether native H6PD is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
H6PD is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label H6PD as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...